Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05291689
What this trial is testing

A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC

Who this might be right for
Inflammatory Bowel DiseasesColitis, Ulcerative
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 39
Not applicableUnknownNCT01793831
What this trial is testing

Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases

Who this might be right for
Inflammatory Bowel DiseaseCrohn's Disease (CD)
The Second Hospital of Nanjing Medical University 800
Testing effectiveness (Phase 2)Study completedNCT04596293
What this trial is testing

Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bridge Biotherapeutics, Inc. 38
Large-scale testing (Phase 3)Study completedNCT00078611
What this trial is testing

A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 462
Testing effectiveness (Phase 2)Ended earlyNCT04987307
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 221
Not applicableStudy completedNCT04424303
What this trial is testing

Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 152
Testing effectiveness (Phase 2)Looking for participantsNCT07470879
What this trial is testing

How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Pfizer 24
Large-scale testing (Phase 3)Ended earlyNCT03759288
What this trial is testing

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's DiseaseIBD
AstraZeneca 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755241
What this trial is testing

AC-101 Tablets in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Accro Bioscience (Suzhou) Limited 153
Large-scale testing (Phase 3)Ended earlyNCT04985968
What this trial is testing

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
InDex Pharmaceuticals 171
Testing effectiveness (Phase 2)Study completedNCT01461317
What this trial is testing

Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 121
Not applicableStudy completedNCT02914717
What this trial is testing

The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Universitaire Ziekenhuizen KU Leuven 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07753850
What this trial is testing

SL-325 in Crohn's Disease Patients

Who this might be right for
Crohn's Disease
Shattuck Labs, Inc. 232
Testing effectiveness (Phase 2)Ended earlyNCT03472690
What this trial is testing

QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Qu Biologics Inc. 20
Not applicableLooking for participantsNCT06962020
What this trial is testing

Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Xijing Hospital of Digestive Diseases 400
Testing effectiveness (Phase 2)Study completedNCT00741910
What this trial is testing

Extension Study of Semapimod 60 mg IV x 3 Days

Who this might be right for
Crohn's Disease
Ferring Pharmaceuticals 15
Large-scale testing (Phase 3)Study completedNCT00409617
What this trial is testing

Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 945
Large-scale testing (Phase 3)Study completedNCT03482635
What this trial is testing

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Boehringer Ingelheim 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242484
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 577
Large-scale testing (Phase 3)Study completedNCT00347048
What this trial is testing

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

Who this might be right for
Ulcerative Colitis
Astellas Pharma Inc 62
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation